Program: Antibacterial Drug Development (ABDD)


Antibacterial Drug Development (ABDD)

Addressing the ABDD Crisis

The increase of bacterial resistance to existing antibacterial therapies—combined with the decrease of research on new antibacterial drugs—has led to a serious public health crisis. At the same time, antibacterial drug development (ABDD) is a long and costly process due to complex protocols, difficulties with enrolling subjects, completing trials, and analyzing the results.

Innovative, collaborative solutions are needed to solve the complex crisis in ABDD. CTTI has worked in four critical areas to address the urgent need for development of new types of antibiotic drugs:

Through this work, CTTI has created a suite of recommendations and resources that stakeholders across the enterprise can use to overcome ABDD challenges and combat this public health crisis.